The Filing Desk

Inogen vs MiMedx Group

Inogen INGN · MiMedx Group MDXG · Health Care Equipment

MiMedx Group reported revenue of $419 million in fiscal 2025, 1.2 times Inogen's $349 million in fiscal 2025. Inogen's revenue grew 3.9% in its latest year, and MiMedx Group's grew 20.0%. Inogen had an operating margin of -8.7%, against 15.3% at MiMedx Group.

Side by side

InogenMiMedx Group
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$349M$419M
Revenue growth3.9%20.0%
Revenue growth a year, last 5 years2.5%11.0%
Gross margin44.2%82.6%
Operating margin−8.7%15.3%
Net margin−6.5%11.6%
Free cash flow−$14M—
Free cash flow margin−3.9%—
Return on capital—43.3%
Net debt to EBITDA—−1.9x
Dividends and buybacks$0M$0M
Change in diluted share count12.5%0.5%
Last close$5.42$3.11
P/E at the last close——
Insider trades, last 12 monthssold $142,519—
Piotroski F-score—7 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
InogenMiMedx Group
Operating margin
Percent of revenue
InogenMiMedx Group
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
InogenMiMedx Group

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Inogen and MiMedx Group pages.